MTOR and Cognitive impairment: The use of rapamycin or hypoxia-inducible factor-dependent target genes that reduce mTOR activity, which leads to the induction of autophagy, ensures that cells adapt to their changing environment, eliminate toxic episodes, and promote cell viability, can be considered as a potential target for restoring cognitive deficits associated with neurodegenerative disorders and neuroinflammaging.